Related Experiment Video

Updated: Aug 14, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

The role of glutamine metabolism in castration-resistant prostate cancer

Bing Zhao1, Jing Wang2, Li Chen1

  • 1Department of Geriatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230002, China.

Asian Journal of Andrology
|January 11, 2023
PubMed

Insights

Targeting glutamine metabolism in advanced prostate cancer (PCa) offers a promising therapeutic strategy. Inhibiting glutamine utilization in tumor cells could improve treatment options for patients with therapy-resistant PCa.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer biology

Background:

  • Tumor cells exhibit metabolic reprogramming, a key area for therapeutic exploration.
  • Advanced and therapy-resistant prostate cancer (PCa) presents unique metabolic characteristics.
  • Glutamine plays a critical role in the metabolic reprogramming of advanced PCa.

Purpose of the Study:

  • To review the metabolic landscape of prostate cancer.
  • To focus on how altered glutamine metabolism impacts therapeutic resistance and disease progression in PCa.
  • To suggest novel therapeutic strategies targeting glutamine metabolism.

Main Methods:

  • Literature review of recent studies on prostate cancer metabolism.
  • Analysis of glutamine's role in PCa metabolic reprogramming.
  • Identification of therapeutic vulnerabilities related to glutamine utilization.

Main Results:

  • Glutamine is central to metabolic reprogramming in advanced PCa.
  • Altered glutamine metabolism is linked to therapeutic resistance and disease progression.
  • Inhibiting glutamine utilization presents a potential therapeutic avenue.

Conclusions:

  • Targeting the glutamine metabolic network is a viable strategy for PCa treatment.
  • Maximally inhibiting glutamine utilization may benefit patients with limited options.
  • Further research into glutamine metabolism could lead to improved clinical outcomes for PCa patients.
Keywords:
castration resistanceglutamine metabolismprostate cancertumor metabolism

More Related Videos

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts06:32

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts

Published on: April 13, 2022

1.8K
Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.9K

Related Concept Videos

Inorganic Nitrogen Assimilation01:22

Inorganic Nitrogen Assimilation

Nitrogen is an essential element in biological systems, forming a crucial component of proteins, nucleic acids, and other cellular constituents. Many bacteria and archaea acquire nitrogen in the form of nitrate (NO₃⁻) or ammonia (NH₃), which are then assimilated into biomolecules through specific enzymatic pathways.Assimilatory Nitrate ReductionWhen nitrate enters the cell, it undergoes a two-step reduction process known as assimilatory nitrate reduction. Initially, the enzyme...
61
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.6K